Dali Pharmaceuticalco.,Ltd (603963.SS)

CNY 2.96

(-3.27%)

Long Term Debt Summary of Dali Pharmaceuticalco.,Ltd

  • Dali Pharmaceuticalco.,Ltd's latest annual long term debt in 2023 was 14.84 Million CNY , down -37.56% from previous year.
  • Dali Pharmaceuticalco.,Ltd's latest quarterly long term debt in 2024 Q1 was 14.02 Million CNY , up 0.02% from previous quarter.
  • Dali Pharmaceuticalco.,Ltd reported annual long term debt of 23.78 Million CNY in 2022, down -38.1% from previous year.
  • Dali Pharmaceuticalco.,Ltd reported annual long term debt of 38.42 Million CNY in 2021, up 155.81% from previous year.
  • Dali Pharmaceuticalco.,Ltd reported quarterly long term debt of 10.51 Million CNY for 2024 Q2, down -25.02% from previous quarter.
  • Dali Pharmaceuticalco.,Ltd reported quarterly long term debt of 10.51 Million CNY for 2024 Q3, down -0.0% from previous quarter.

Annual Long Term Debt Chart of Dali Pharmaceuticalco.,Ltd (2023 - 2012)

Historical Annual Long Term Debt of Dali Pharmaceuticalco.,Ltd (2023 - 2012)

Year Long Term Debt Long Term Debt Growth
2023 14.84 Million CNY -37.56%
2022 23.78 Million CNY -38.1%
2021 38.42 Million CNY 155.81%
2020 15.01 Million CNY 12901902227551027000.0%
2019 - CNY 0.0%
2018 - CNY 0.0%
2017 - CNY 0.0%
2016 - CNY 0.0%
2015 - CNY 0.0%
2014 - CNY 0.0%
2013 - CNY -100.0%
2012 25 Million CNY 0.0%

Peer Long Term Debt Comparison of Dali Pharmaceuticalco.,Ltd

Name Long Term Debt Long Term Debt Difference
Hubei Jumpcan Pharmaceutical Co., Ltd. 1.43 Million CNY -935.228%
Yabao Pharmaceutical Group Co., Ltd 3.36 Million CNY -340.745%
Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited 3.32 Billion CNY 99.553%
Harbin Pharmaceutical Group Co., Ltd. 32.62 Million CNY 54.49%
Tasly Pharmaceutical Group Co., Ltd 1.41 Billion CNY 98.949%
Zhejiang Medicine Co., Ltd. 230.54 Million CNY 93.559%
Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited 241.03 Million CNY 93.839%
Lionco Pharmaceutical Group Co.,Ltd. 445.18 Million CNY 96.664%
Humanwell Healthcare (Group) Co.,Ltd. 1.65 Billion CNY 99.1%
Ginwa Enterprise (Group) Inc. 5.42 Million CNY -173.503%
Joincare Pharmaceutical Group Industry Co.,Ltd. 3.12 Billion CNY 99.524%
Zhejiang Shapuaisi Pharmaceutical Co.,Ltd. 70.75 Million CNY 79.012%
China Animal Husbandry Industry Co., Ltd. 899.03 Million CNY 98.348%
Jiangsu Jibeier Pharmaceutical Co., Ltd. - CNY -Infinity%
Zhejiang Huahai Pharmaceutical Co., Ltd. 4.02 Billion CNY 99.631%
Shanghai Haoyuan Chemexpress Co., Ltd. 229.23 Million CNY 93.522%
Ningbo Menovo Pharmaceutical Co., Ltd. 759.64 Million CNY 98.045%
Zhejiang Jiuzhou Pharmaceutical Co., Ltd 389.05 Million CNY 96.183%
Chongqing Taiji Industry(Group) Co.,Ltd 341.6 Million CNY 95.653%
HPGC Renmintongtai Pharmaceutical Corporation 29.4 Million CNY 49.507%
Nanjing Well Pharmaceutical Group Co.,Ltd. 104.06 Million CNY 85.73%
Tianjin Tianyao Pharmaceuticals Co., Ltd. 277 Million CNY 94.639%
Henan Lingrui Pharmaceutical Co., Ltd. 6.96 Million CNY -113.29%
Shenzhen Chipscreen Biosciences Co., Ltd. 1.02 Billion CNY 98.548%
Guizhou Yibai Pharmaceutical Co., Ltd. 387.22 Million CNY 96.165%
Jiangsu Kanion Pharmaceutical Co.,Ltd. 1.92 Million CNY -671.205%
Zhongzhu Healthcare Holding Co.,Ltd 12.76 Million CNY -16.333%
Beijing Tongrentang Co., Ltd 1.42 Billion CNY 98.961%
KPC Pharmaceuticals, Inc. 107.56 Million CNY 86.194%
Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co.,Ltd. 10.95 Million CNY -35.578%
North China Pharmaceutical Company Ltd. 4.08 Billion CNY 99.636%
China Resources Double-Crane Pharmaceutical Co.,Ltd. 29.94 Million CNY 50.418%
Tibet Weixinkang Medicine Co., Ltd. 3.81 Million CNY -288.85%
China National Medicines Corporation Ltd. 205.07 Million CNY 92.759%
Zhejiang Hisun Pharmaceutical Co., Ltd. 2.39 Billion CNY 99.381%
Heilongjiang ZBD Pharmaceutical Co., Ltd. 1.29 Billion CNY 98.856%
ChengDu ShengNuo Biotec Co.,Ltd. 189.19 Million CNY 92.151%
Changchun BCHT Biotechnology Co. -9.85 Million CNY 250.661%
Zhejiang Shengda Bio-Pharm Co., Ltd. 144 Million CNY 89.688%
Shanghai Jiaoda Onlly Co.,Ltd 120.22 Million CNY 87.649%
Jiang Zhong Pharmaceutical Co.,Ltd 1.04 Million CNY -1317.344%
Mayinglong Pharmaceutical Group Co., LTD. 128.45 Million CNY 88.44%
Cisen Pharmaceutical Co., Ltd. 132.53 Million CNY 88.796%
Hunan Warrant Pharmaceutical Co.,Ltd 17.1 Million CNY 13.193%
Shanghai Fosun Pharmaceutical (Group) Co., Ltd. 13.5 Billion CNY 99.89%
Jianmin Pharmaceutical Group Co.,Ltd. 30.29 Million CNY 50.983%
Hunan Fangsheng Pharmaceutical Co., Ltd. 174 Million CNY 91.466%
Guangxi Wuzhou Zhongheng Group Co.,Ltd 553.47 Million CNY 97.317%
Guobang Pharma Ltd. 451.7 Million CNY 96.713%
Shaanxi Kanghui Pharmaceutical Co., Ltd. 283.87 Million CNY 94.769%
Kangmei Pharmaceutical Co., Ltd. 188.16 Million CNY 92.108%
Shandong Buchang Pharmaceuticals Co., Ltd. 2.09 Billion CNY 99.292%
Zhejiang Starry Pharmaceutical Co.,Ltd. 734.44 Million CNY 97.978%
Henan Taloph Pharmaceutical Stock Co.,Ltd 183.8 Million CNY 91.921%
ZhuZhou QianJin Pharmaceutical Co.,Ltd 38.46 Million CNY 61.393%
Nanjing King-Friend Biochemical Pharmaceutical Co., Ltd 512.37 Million CNY 97.102%
Beijing Sun-Novo Pharmaceutical Research Co., Ltd. 40.62 Million CNY 63.445%
Shanghai Shyndec Pharmaceutical Co., Ltd. 1.03 Billion CNY 98.56%
Shanghai Yizhong Pharmaceutical Co., Ltd. - CNY -Infinity%
Tibet Rhodiola Pharmaceutical Holding Co. 1.12 Million CNY -1219.452%
Sichuan Huiyu Pharmaceutical Co., Ltd. 2.04 Million CNY -624.963%
Zhejiang Cheng Yi Pharmaceutical Co., Ltd. 316.84 Million CNY 95.313%
CanSino Biologics Inc. 1.07 Billion CNY 98.618%
Jiangsu Lianhuan Pharmaceutical Co., Ltd. 82.91 Million CNY 82.09%
Shandong Lukang Pharmaceutical Co.,Ltd. 1.3 Billion CNY 98.866%